A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
-
Published:2018-03
Issue:
Volume:Volume 10
Page:53-67
-
ISSN:1179-1314
-
Container-title:Breast Cancer: Targets and Therapy
-
language:en
-
Short-container-title:BCTT
Author:
Liang Yayun,
Mafuvadze BenfordORCID,
Besch-Williford Cynthia,
Hyder Salman M
Publisher
Informa UK Limited
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献